INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $46,000 | +17.9% | 39,300 | +113.4% | 0.02% | +280.0% |
Q1 2018 | $39,000 | -75.3% | 18,418 | -76.3% | 0.01% | -73.7% |
Q4 2017 | $158,000 | +163.3% | 77,665 | +73.4% | 0.02% | +26.7% |
Q2 2016 | $60,000 | -27.7% | 44,800 | +322.8% | 0.02% | -70.0% |
Q4 2015 | $83,000 | – | 10,597 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
Bleichroeder LP | 250,000 | $298,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |